A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ...

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...

Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

Olympus Corp. of the Americas, a global MedTech company committed to making people's lives healthier, safer and more ...

Olympus today announced the U.S. launch of its most advanced single-use fine needle biopsy device used in ultrasound-guided ...

Hamilton, a global leader in precision liquid handling and laboratory automation, and nRichDX, a leader in liquid biopsy ...

Officials at Portneuf Medical Center in Pocatello and Bingham Memorial Hospital in Blackfoot recently announced a step ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

The global liquid biopsy market is experiencing substantial growth, driven by increasing demand for non-invasive diagnostic technologies that detect molecular biomarkers using liquid samples, thus ...

Two major eastern Idaho hospitals are taking a groundbreaking step to improve cancer care through a new technology that ...